Filing Details
- Accession Number:
- 0001209191-23-020044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-20 16:29:58
- Reporting Period:
- 2023-03-16
- Accepted Time:
- 2023-03-20 16:29:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc. | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 133831168 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272354 | Ron Cohen | C/O Acorda Therapeutics, Inc. 2 Blue Hill Plaza, 3Rd Floor Pearl River NY 10965 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-16 | 10,156 | $0.60 | 139,757 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-03-17 | 10,000 | $0.65 | 149,757 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.590 to $0.600. The reporting person undertakes to provide to Acorda Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
